Understanding social isolation and cognition in adolescents with Tourette syndrome
Social Isolation and Social Cognition in Adolescents with Tourette Syndrome
['FUNDING_OTHER'] · VANDERBILT UNIVERSITY MEDICAL CENTER · NIH-11137898
This study looks at how feeling alone affects teenagers with Tourette syndrome and how well they understand social situations, hoping to find ways to help them connect better with others.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VANDERBILT UNIVERSITY MEDICAL CENTER (nih funded) |
| Locations | 1 site (NASHVILLE, UNITED STATES) |
| Trial ID | NIH-11137898 on ClinicalTrials.gov |
What this research studies
This research investigates how social isolation affects adolescents with Tourette syndrome (TS) and explores their social cognition. The study aims to quantify how many adolescents with TS experience social isolation and to assess their understanding of social cues through various assessments, including eye-tracking technology. By focusing on these aspects, the research seeks to identify risk factors contributing to social problems in this population. The findings could lead to improved behavioral therapies tailored to enhance social interactions for adolescents with TS.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 20 who have been diagnosed with Tourette syndrome.
Not a fit: Patients outside the age range of 12 to 20 or those without a diagnosis of Tourette syndrome may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better therapeutic strategies that improve social functioning and reduce isolation in adolescents with Tourette syndrome.
How similar studies have performed: Previous research has shown that addressing social cognition in neurodevelopmental disorders can lead to significant improvements in social outcomes, suggesting this approach has potential for success.
Where this research is happening
NASHVILLE, UNITED STATES
- VANDERBILT UNIVERSITY MEDICAL CENTER — NASHVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WATSON, KELLY HAKER — VANDERBILT UNIVERSITY MEDICAL CENTER
- Study coordinator: WATSON, KELLY HAKER
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.